Medicare no longer covers Wegovy specifically for weight loss purposes, though coverage may still be available when ...

In a significant move, the Biden administration said Jan. 17, 2025 that Ozempic, Wegovy and other new drugs have been selected for Medicare's price negotiations to go into effect in 2027.

Also: A Medicare crisis and doctors’ concerns with Kennedy’s new coronavirus vaccine policy.

The portfolio continues to invest in companies we believe are strong and improving but whose share price performance does not ...

The percentage of adults prescribed a GLP-1 drug like Wegovy or Zepbound jumped almost sevenfold over the past five years, ...

Wegovy isn’t typically covered by insurance — that applies to both private insurance and Medicare. Insurance providers often classify weight loss treatment as cosmetic, despite its many health ...

South Carolina Medicaid approved GLP-1s to treat obesity, placing it among the few state programs covering the drugs. But access remains limited.

The supply of GLP-1 drugs has been increasing, but they’re still expensive for most patients. Here are answers to some ...

In most cases, Medicare will not pay for the drugs to treat ... generic versions of Ozempic and Wegovy could become available as soon as next year. The company has applied for regulatory approval ...